The PROS1 and FN1 others 12 genes alternations were identified as important diagnostic biomarkers for thyroid cancer through the meta-analysis the gene expression profiling of clinical thyroid nodules [41]. This evidence concerns the gene PROS1 and thyroid gland carcinoma.